Your free order overview

You currently have not items to display

Your contact details

Title

Gender

First Name*

Last Name*

Email address*

Phone number

Country

Street

Number

City

Postal code

I agree to the Legal Notice

*

This is a required field

Thank you!

Thank you for choosing Janssen Medical Cloud for ordering your materials.

Home
Services
Services
- Ask J&J

METASTASIS-FREE SURVIVAL*1

METASTASIS-FREE SURVIVAL^*1

*nmCRPC with a PSA doubling time of ≤10 months despite ADT.

REFERENCE
1- Smith MR, et al. N Engl J Med. 2018;378:1408–18.

erleada_logo

erleada_logo

CP-142079

This site is published by ©Johnson & Johnson Innovative Medicine NV which is solely responsible for its content. It is intended for European, Middle Eastern and African Healthcare professionals.

Johnson & Johnson Pharmaceutica NV

Legal Notice Cookie Policy Privacy Policy

Cookie Settings